Seymour J - Search Results

1

Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients.

Gandhi MK, Lambley E, Duraiswamy J, Dua U, Smith C, Elliott S, Gill D, Marlton P, Seymour J, Khanna R. Gandhi MK, et al. Among authors: seymour j. Blood. 2006 Oct 1;108(7):2280-9. doi: 10.1182/blood-2006-04-015164. Epub 2006 Jun 6. Blood. 2006. PMID: 16757686 Free article.

2

Autografting followed by rituximab for chemosensitive mantle cell lymphoma: a pilot study and literature review.

Grigg AP, Bashford J, Seymour JF, Shuttleworth P, Norris D, Hertzberg M, Gill D, Waugh M, Saal R, Marlton P. Grigg AP, et al. Among authors: seymour jf. Leuk Lymphoma. 2005 Jun;46(6):851-60. doi: 10.1080/10428190500052461. Leuk Lymphoma. 2005. PMID: 16019529 Clinical Trial.

3

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.

Gandhi MK, Lambley E, Burrows J, Dua U, Elliott S, Shaw PJ, Prince HM, Wolf M, Clarke K, Underhill C, Mills T, Mollee P, Gill D, Marlton P, Seymour JF, Khanna R. Gandhi MK, et al. Among authors: seymour jf. Clin Cancer Res. 2006 Jan 15;12(2):460-4. doi: 10.1158/1078-0432.CCR-05-2008. Clin Cancer Res. 2006. PMID: 16428487

4

The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization.

Keane C, Gibbs S, Seymour JF, Mills AK, Grimmett K, Van Kuilenberg R, Saal R, Gill D, Prince HM, Marlton P, Mollee P. Keane C, et al. Hematol Oncol. 2006 Sep;24(3):159-63. doi: 10.1002/hon.784. Hematol Oncol. 2006. PMID: 16775841

5

Functional reversion of antigen-specific CD8+ T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope.

Smith C, Cooper L, Burgess M, Rist M, Webb N, Lambley E, Tellam J, Marlton P, Seymour JF, Gandhi M, Khanna R. Smith C, et al. Among authors: seymour jf. J Immunol. 2006 Oct 1;177(7):4897-906. doi: 10.4049/jimmunol.177.7.4897. J Immunol. 2006. PMID: 16982932

6

Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy.

Lane SW, Crawford J, Kenealy M, Cull G, Seymour JF, Prince HM, Marlton P, Gill D, Mollee PN. Lane SW, et al. Among authors: seymour jf. Leuk Lymphoma. 2006 Sep;47(9):1813-7. doi: 10.1080/10428190600632832. Leuk Lymphoma. 2006. PMID: 17064993

7

Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma.

Gandhi MK, Moll G, Smith C, Dua U, Lambley E, Ramuz O, Gill D, Marlton P, Seymour JF, Khanna R. Gandhi MK, et al. Blood. 2007 Aug 15;110(4):1326-9. doi: 10.1182/blood-2007-01-066100. Epub 2007 Apr 16. Blood. 2007. PMID: 17438085 Free PMC article.

8

A >or=1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor acute myeloid leukemia and predicts subsequent morphologic relapse.

Lane S, Saal R, Mollee P, Jones M, Grigg A, Taylor K, Seymour J, Kennedy G, Williams B, Grimmett K, Griffiths V, Gill D, Hourigan M, Marlton P. Lane S, et al. Among authors: seymour j. Leuk Lymphoma. 2008 Mar;49(3):517-23. doi: 10.1080/10428190701817266. Leuk Lymphoma. 2008. PMID: 18297529

9

A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma.

Mitchell PL, Marlton P, Grigg A, Seymour JF, Hertzberg M, Enno A, Herrmann R, Bond R, Arthur C. Mitchell PL, et al. Leuk Lymphoma. 2008 May;49(5):924-31. doi: 10.1080/10428190802007700. Leuk Lymphoma. 2008. PMID: 18464112 Clinical Trial.

10

Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma.

Morschhauser F, Marlton P, Vitolo U, Lindén O, Seymour JF, Crump M, Coiffier B, Foà R, Wassner E, Burger HU, Brennan B, Mendila M. Morschhauser F, et al. Among authors: seymour jf. Ann Oncol. 2010 Sep;21(9):1870-1876. doi: 10.1093/annonc/mdq027. Epub 2010 Feb 15. Ann Oncol. 2010. PMID: 20157180 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,441 results

Search Page

Filters